BAX Bank of America maintains hold rating

What happened: On March 17, Bank of America Securities analyst Travis Steed maintained a 'Hold' rating on Baxter International Inc. (NYSE:BAX), with a price target of $24. This follows a downgrade in the S&P's outlook on Baxter's credit rating, citing potential headwinds from higher costs and slower growth.

Market impact: Baxter, a global healthcare company with a market cap of $9.7 billion, provides essential medical products and therapies. The hold rating and credit outlook downgrade may impact investors' sentiment towards Baxter and other mid-cap value stocks, potentially leading to valuation repricing in the sector.

What to watch next: Baxter's earnings report on April 26 will provide insights into its financial health and growth prospects. Additionally, investors should monitor any updates on Baxter's cost management strategies and the broader healthcare sector's performance, as these could influence the company's stock valuation.